JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v7i3.4921ArticleRelationship Between the Efficacy of Low-Dose Glucocorticoids Combined with Tacrolimus in the Treatment of Adult Idiopathic Membranous Nephropathy and the Level of Serum Anti-PLA2R Antibodieshttps://artdesignp.com/journal/JCNR/7/3/10.26689/jcnr.v7i3.4921GuoShanshan,GuoLi,LiJiandong,GongYoulan,XuYang,ChenHang,ZhengXijie2023732023-05-30Objective: To further evaluate the efficacy and safety of low-dose glucocorticoids combined with tacrolimus in the treatment of adult idiopathic membranous nephropathy (IMN) in a clinical setting. Methods: We carried out a single-center prospective study of 88 patients with IMN who were admitted into the Affiliated Hospital of Hebei University from January 2019 to December 2021, and the participants were divided into two groups based on their serum anti-PLA2R antibody levels: the negative group and the positive group. 46 patients were positive for anti-PLA2R antibodies and 42 were negative. Results: After 6 months of treatment, the serum albumin, cholesterol, and 24h urine protein quantification in the anti-PLA2R negative group improved more significantly compared to the positive group (P < 0.05); after 6 months of treatment, the remission rate of the positive group was significantly lower than that of the negative group, and (P < 0.05); Conclusion: After treatment with tacrolimus combined with low-dose glucocorticoids, patients with idiopathic membranous nephropathy who were tested positive for anti-PLA2R antibodies had a higher overall remission rate compared those who were tested negative for serum anti-PLA2R antibodies.

Xia L, Huang Q, Cao Q, et al., 2023, Efficacy of Tacrolimus Combined with Glucocorticoids in the Treatment of Idiopathic Membranous Nephropathy and the Effect on Serum PLA2R Antibody and Kim-1 Levels. Journal of Clinical and Experimental Medicine, 22(02): 158–161.

Qiu B, Yuan L, Li Y, et al., 2022, Relationship Between Clinical Efficacy of Low-Dose Glucocorticoids Combined with Tacrolimus in the Treatment of Idiopathic Membranous Nephropathy and Serum Anti-PLA2R Antibody. Practical Drugs and Clinics, 25(12): 1090–1093.

Liu J, Chen H, Li C, et al., 2021, Analysis of the Relationship Between Serum Anti-PLA2R Antibody and Urinary EGF/MCP-1 and Clinical Outcomes and Prognosis of Patients with Idiopathic Membranous Nephropathy. Clinical Misdiagnosis and Mistreatment, 34(03): 79–84.

Song X, Luo H, Zhao T, 2021, Relationship Between Serum Chemerin and Anti-PLA2R Antibody Levels and Disease in Idiopathic Membranous Nephropathy. Journal of Tropical Medicine, 21(01): 94–98 + 2.

Shen L, 2020, Influence of Serum Anti-PLA2R Antibody Level on the Efficacy of Torch Flower Root Combined with Rehmannia Polysaccharide in the Treatment of Idiopathic Membranous Nephropathy. Modern Health Care, 20(Z6): 58–60.

Liu M, Zhuang Y, 2020, Relationship Between the Efficacy of Hormone Combined with Rehmannia Polysaccharide in the Treatment of Adult Idiopathic Membranous Nephropathy and Serum Anti-PLA2R Antibody Levels. Chinese Journal of Integrated Chinese and Western Medicine and Nephrology, 21(02): 113–116.

Huang X, Xu D, 2010, Pharmacotherapeutics of Nephropathy, Chemical Industry Press, Beijing, 18–25.

Xie X, Xie B, Zheng Q, et al., 2021, Study on the Efficacy and Safety of Cyclophosphamide Intravenous Shock Combined with Glucocorticoids in the Treatment of Idiopathic Membranous Nephropathy. Journal of the Third Military Medical University, 43(12): 1173–1178.